# ClinicalTrials.gov record NCT01121939

> PeptideScanner retained ClinicalTrials.gov record NCT01121939 at 2026-07-30T21:38:42.856Z. Its registry update date was 2016-02-05, and PeptideScanner's reviewed identity mapping was octreotide.

- Evidence object: `story:clinicaltrials-gov-nct01121939-octreotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2016-02-05
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01121939-octreotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01121939-octreotide-v1.json
- Content SHA-256: `a33ece4dd89f8e65702a0b4968da8979070bf5155cc4e9d7c9d7f4bca1632b54`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT01121939 ([`ctg-observation-nct01121939-2016-02-05-71f0eb4a1f21`](#source-ctg-observation-nct01121939-2016-02-05-71f0eb4a1f21))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01121939 at 2026-07-30T21:38:42.856Z. Its registry update date was 2016-02-05, and PeptideScanner's reviewed identity mapping was octreotide. ([`ctg-observation-nct01121939-2016-02-05-71f0eb4a1f21`](#source-ctg-observation-nct01121939-2016-02-05-71f0eb4a1f21))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01121939 at 2026-07-30T21:38:42.856Z. Its registry update date was 2016-02-05, and PeptideScanner's reviewed identity mapping was octreotide. ([`ctg-observation-nct01121939-2016-02-05-71f0eb4a1f21`](#source-ctg-observation-nct01121939-2016-02-05-71f0eb4a1f21))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01121939-2016-02-05-71f0eb4a1f21`](#source-ctg-observation-nct01121939-2016-02-05-71f0eb4a1f21))

## Sources

<a id="source-ctg-observation-nct01121939-2016-02-05-71f0eb4a1f21"></a>
- **ClinicalTrials.gov record NCT01121939 · retained source version 2016-02-05:71f0eb4a1f2152691571387f28c59d0dcafb5eac84665f2dc852c2c918c94073** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01121939) (`ctg-observation-nct01121939-2016-02-05-71f0eb4a1f21`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01121939." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01121939-octreotide-v1.json SHA-256: a33ece4dd89f8e65702a0b4968da8979070bf5155cc4e9d7c9d7f4bca1632b54.